Fatal infantile cardiopathy caused by phosphorylase b kinase deficiency J Pediatr 1988;113:82–85 27 Amit R, Bashan N, Abarbanel JM, et al Fatal familial infantile glycogen storage disease: multisystem phosphofructokinase deficiency Muscle Nerve 1992;15:455–458 28 Finsterer J, Stollberger C, Kopsa W Neurolgic and cardiac progression of glycogenosis type VII over an eight-year period South Med J 2002;95(12):1436–1440 29 Taylor D, Blaser SI, Burrows PE, et al Arteriopathy and coarctation of the abdominal aorta in children with mucopolysaccharidosis: imaging findings AJR Am J Roentgenol 1991;157:819–823 30 Bolourchi M, Renella P, Wang RY Aortic root dilatation in mucopolysaccharidosis I-VII Int J Mol Sci 2016;17(12):pii: E2004 31 Scott HS, Bunge S, Gal A, et al Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications Hum Mutat 1995;6(4):288–302 32 Terlato NJ, Cox GF Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature Genet Med 2003;5(4):286–294 33 Clarke LA Mucopolysaccharidosis type I Pagon RA, Adam MP, Ardinger HH, et al GeneReviews University of Washington,: Seattle (WA); 2002 [Seattle; 1993-2017; [updated 2016 Feb 11] 34 Donaldson MDC, Pennock CA, Berry PJ, et al Hurler syndrome with cardiomyopathy in infancy J Pediatr 1989;114:429–430 35 Stephan MJ, Stevens EL Jr, Wenstrup RJ, et al Mucopolysaccharidosis I presenting with endocardial fibroelastosis in infancy Am J Dis Child 1989;143(7):782–784 36 Krovetz LJ, Lorincz AE, Schiebler GI Cardiovascular manifestations of the hurler syndrome: hemodynamic and angiocardiographic observations in 15 patients Circulation 1965;31:132–141 37 Hinek A, Wilson SE Impaired elastogenesis in hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly Am J Pathol 2000;156(3):925–938 38 Krivit W Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases Springer Semin Immunopathol 2004;26(1–2):119–132 39 Braunlin EA, Berry JM, Whitley CB Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I Am J Cardiol 2006;98(3):416–418 40 Fischer TA, Lehr HA, Nixdorff U, Meyer J Combined aortic and mitral stenosis in mucopolysaccharidosis type I-S (ullrich-scheie syndrome) Heart 1999;81(1):97–99 41 Minakata K, Konishi Y, Matsumoto M, Miwa S Surgical treatment for Scheie's syndrome (mucopolysaccharidosis type I-S): report of two cases Jpn Circ J 1998;62(9):700–703 42 Gross DM, Williams JC, Caprioli C, Domingues B, Howell RR Echocardiographic abnormalities in the mucopolysaccharide storage diseases Am J Cardiol 1988;61:170–176 43 Sukegawa-Hayasaka K, Kato Z, Nakamura H, et al Effect of hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis J Inherit Metab Dis 2006;29(6):755–761 44 Tuschl K, Gal A, Paschke E, Kircher S, Bodamer OA Mucopolysaccharidosis type II in females: case report and review of literature Pediatr Neurol 2005;32(4):270–272 45 Muenzer J, Gucsavas-Calikoglu M, McCandless